Svetlana Lakunina
Overview
Explore the profile of Svetlana Lakunina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gordon M, Khudr J, Sinopoulou V, Lakunina S, Rane A, Akobeng A
BMJ Open Gastroenterol
. 2024 Apr;
11(1).
PMID: 38631808
Objective: Our objective was to perform a systemic evaluation of the risk of bias in randomised controlled trial (RCT) reports published on inflammatory bowel disease (IBD). Design: We assessed the...
2.
Down B, Lakunina S, Maynard N, Markar S, Gordon-Weeks A
Eur J Surg Oncol
. 2024 Mar;
50(4):108231.
PMID: 38461569
Oligometastatic oesophagogastric cancer was recently defined by consensus as the presence of no more than two metastases and an 18-week period of oncological stability during chemotherapy. The number of patients...
3.
Gordon M, Sinopoulou V, Lakunina S, Gjuladin-Hellon T, Bracewell K, Akobeng A
Cochrane Database Syst Rev
. 2023 May;
5:CD014821.
PMID: 37140025
Background: People with inflammatory bowel disease (IBD) require intensive follow-up with frequent consultations after diagnosis. IBD telehealth management includes consulting by phone, instant messenger, video, text message, or web-based services....
4.
Afzal B, Cirocchi R, Dawani A, Desiderio J, Di Cintio A, Nardo D, et al.
World J Emerg Surg
. 2023 Jan;
18(1):10.
PMID: 36707812
Introduction: Recent evidence confirms that the treatment of acute appendicitis is not necessarily surgical, and selected patients with uncomplicated appendicitis can benefit from a non-operative management. Unfortunately, no cost-effective test...
5.
Gordon M, Lakunina S, Sinopoulou V, Akobeng A
World J Gastroenterol
. 2021 Dec;
27(43):7572-7581.
PMID: 34887650
Background: Of 25% of randomised controlled trials (RCTs) on interventions for inflammatory bowel disease (IBD) have no power calculation. Aim: To systematically review RCTs reporting interventions for the management of...
6.
Iheozor-Ejiofor Z, Lakunina S, Gordon M, Akintelure D, Sinopoulou V, Akobeng A
United European Gastroenterol J
. 2020 Oct;
9(1):47-53.
PMID: 33104495
Background: Sample-size estimation is an important factor in designing a clinical trial. A recent study found that 65% of Cochrane systematic reviews had imprecise results. Objective: This study set out...